Professional Summary
Professional Overview
Greg Pyszczymuka is an experienced pharmaceutical executive with over 18 years of demonstrated success in driving commercial strategy and operations. As the Chief Commercial Officer at Aytu BioPharma, he is responsible for leading the company's global commercial initiatives, including the launch and commercialization of its specialty pharmaceutical products. Pyszczymuka's industry expertise spans various therapeutic areas, with a particular focus on rare and orphan diseases.
Experience Summary
Current Role
As the Chief Commercial Officer at Aytu BioPharma since October 2021, Pyszczymuka oversees all commercial activities, including sales, marketing, market access, and channel strategy. He has been instrumental in guiding the company's commercial strategy and leading the successful launch of its products. Under his leadership, Aytu BioPharma has achieved significant growth and market share expansion.
Career Progression
Prior to his current role, Pyszczymuka held several senior commercial leadership positions at leading pharmaceutical companies. He served as the Executive Vice President of Commercial Operations at Aytu BioPharma, where he was responsible for developing and executing the commercial strategy for the company's product portfolio. Before that, he held various roles at Neos Therapeutics, Inc., including Vice President of Head of Commercial and Vice President of Commercial Strategy & Market Access. Pyszczymuka also gained valuable experience in commercial strategy and access at Aqua Pharmaceuticals, an Almirall Company, and Iroko Pharmaceuticals, LLC.
Throughout his career, Pyszczymuka has demonstrated a strong track record of driving commercial success, launching new products, and building high-performing teams. His ability to navigate complex regulatory environments and implement effective go-to-market strategies has contributed to the growth and profitability of the organizations he has served.
Academic Background
Pyszczymuka holds a Bachelor's degree from a leading university, where he specialized in a relevant field of study. His academic achievements and specialized knowledge have been instrumental in shaping his professional development and industry expertise.
Areas of Expertise
- Pharmaceutical commercial strategy and operations
- Product launch and commercialization
- Market access and payer strategy
- Channel management and distribution
- Sales force optimization and team leadership
- Strategic planning and execution
- Cross-functional collaboration and stakeholder management
Professional Impact
Pyszczymuka's contributions to the pharmaceutical industry have been recognized by his peers and industry leaders. He has been instrumental in driving the commercial success of several specialty pharmaceutical products, resulting in increased patient access and improved health outcomes. Additionally, Pyszczymuka's service on the Board of Directors at Evoke Pharma demonstrates his strategic leadership and commitment to the industry.
Conclusion
With his extensive experience, strong commercial acumen, and proven track record of success, Greg Pyszczymuka is a valuable asset to Aytu BioPharma and the broader pharmaceutical industry. As the Chief Commercial Officer, he continues to lead the company's commercial initiatives, driving growth, and ensuring the effective launch and commercialization of its product portfolio.
